FDA Drug Shortages — Page 3

1,660 drug shortages total

Browse FDA drug shortages by generic name, company, and status. RegDataLab tracks 1,660 drug shortages from official FDA sources, updated on an ongoing basis.

FDA Drug Shortages (page 3 of 34)

Drug shortages	Details
Lorlatinib Tablet	To Be Discontinued — Pfizer Inc.
Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release	To Be Discontinued — Amneal Pharmaceuticals
Leflunomide Tablet	To Be Discontinued — Sanofi-Aventis U.S. LLC
Leflunomide Tablet	To Be Discontinued — Sanofi-Aventis U.S. LLC
Semaglutide Tablet	To Be Discontinued — Novo Nordisk, Inc.
Dexmedetomidine Hydrochloride Injection	Current — Azurity Pharmaceuticals, Inc
Ifosfamide Injection	Current — Baxter Healthcare
Dexmedetomidine Hydrochloride Injection	Current — Azurity Pharmaceuticals, Inc
Liraglutide Injection	To Be Discontinued — Teva Pharmaceuticals USA, Inc.
Quinapril/Hydrochlorothiazide Tablet	Current — Pfizer Inc.
Bupivacaine Hydrochloride Injection	Current — Hospira, Inc., a Pfizer Company
Cromolyn Sodium Concentrate	Current — Ailex Pharmaceuticals
Alteplase Injection	To Be Discontinued — Genentech, Inc
Sulconazole Nitrate Solution	To Be Discontinued — Journey Medical Corporation
Carboplatin Injection	Current — Avyxa Pharma, LLC
Sulconazole Nitrate Solution	To Be Discontinued — Journey Medical Corporation
Gadoterate Meglumine Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Activated Charcoal Oral Suspension	To Be Discontinued — Padagis US LLC
Cisatracurium Besylate Injection	To Be Discontinued — Hospira, Inc., a Pfizer Company
Activated Charcoal Oral Suspension	To Be Discontinued — Padagis US LLC
Activated Charcoal Oral Suspension	To Be Discontinued — Padagis US LLC
Quinapril/Hydrochlorothiazide Tablet	Current — Pfizer Inc.
Bupivacaine Hydrochloride Injection	Current — Hospira, Inc., a Pfizer Company
Gadoterate Meglumine Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Activated Charcoal Oral Suspension	To Be Discontinued — Padagis US LLC
Gadoterate Meglumine Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Sodium Acetate Injection	Current — Milla Pharmaceuticals
Icatibant Acetate Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Icatibant Acetate Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Gadoterate Meglumine Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Dehydrated Alcohol Injection, Solution	To Be Discontinued — Accord Healthcare Inc.
Cisatracurium Besylate Injection	To Be Discontinued — Hospira, Inc., a Pfizer Company
Quinapril/Hydrochlorothiazide Tablet	Current — Pfizer Inc.
Activated Charcoal Oral Suspension	To Be Discontinued — Padagis US LLC
Carboplatin Injection	Current — Avyxa Pharma, LLC
Iron Sucrose Injection	To Be Discontinued — Mylan Institutional, a Viatris Company
Sulconazole Nitrate Solution	To Be Discontinued — Journey Medical Corporation
Cromolyn Sodium Concentrate	Current — Ailex Pharmaceuticals
Bupivacaine Hydrochloride Injection	Current — Hospira, Inc., a Pfizer Company
Tiagabine Hydrochloride Tablet	To Be Discontinued — Teva Pharmaceuticals USA, Inc.
Lamotrigine Tablet, Extended Release	To Be Discontinued — Par Health, Inc.
Lamotrigine Tablet, Extended Release	To Be Discontinued — Par Health, Inc.
Azithromycin Tablet	To Be Discontinued — Pfizer Inc.
Aprepitant Oral Powder for Suspension	To Be Discontinued — Merck Sharp & Dohme LLC
Idelalisib Tablet	To Be Discontinued — Gilead Sciences, Inc.
Dextrose Monohydrate 5% Injection	Current — Baxter Healthcare
Dextrose Monohydrate 5% Injection	Current — Baxter Healthcare
Ketorolac Tromethamine Tablet	To Be Discontinued — Mylan Pharmaceuticals Inc., a Viatris Company
Etravirine Tablet	To Be Discontinued — Janssen Research and Development
Tiagabine Hydrochloride Tablet	To Be Discontinued — Teva Pharmaceuticals USA, Inc.